Cargando…
11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome
The metabolic syndrome describes a clustering of risk factors—visceral obesity, dyslipidaemia, insulin resistance, and salt-sensitive hypertension—that increases mortality related to cardiovascular disease, type 2 diabetes, cancer, and non-alcoholic fatty liver disease. The prevalence of these concu...
Autor principal: | Bailey, Matthew A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686277/ https://www.ncbi.nlm.nih.gov/pubmed/29138984 http://dx.doi.org/10.1007/s11906-017-0797-z |
Ejemplares similares
-
Hypertension and Metabolic Syndrome in Persons with HIV
por: Masenga, Sepiso K., et al.
Publicado: (2020) -
Migrating Populations and Health: Risk Factors for Cardiovascular Disease and Metabolic Syndrome
por: Rosenthal, Talma, et al.
Publicado: (2022) -
Time-Restricted Eating in Metabolic Syndrome–Focus on Blood Pressure Outcomes
por: Duan, Daisy, et al.
Publicado: (2022) -
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
por: Herat, Lakshini Y., et al.
Publicado: (2022) -
Role of MicroRNA in Endothelial Dysfunction and Hypertension
por: Nemecz, Miruna, et al.
Publicado: (2016)